HEALTH.2012.2.1.2-2
HEALTH.2012.2.1.2-2
4 projects · €46,461,955 total EU contribution (project-level) · 56 participating organizations · 15 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€46,461,955
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (12)
- France (12)
- SE (6)
- Netherlands (5)
- UK (5)
- BE (3)
- AT (2)
- DK (2)
- IL (2)
- US (2)
- CH (1)
- EL (1)
- FI (1)
- NO (1)
- NZ (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- GENEXPLAIN2 projects · DE
- UGOT - GOETEBORGS UNIVERSITET/UNIVERSITY OF GOTHENBURG2 projects · SE
- LIFEGLIMMER GMBH2 projects · DE
- ABGI FRANCE1 projects · FR
- AMC1 projects · NL
- UNIVERSITAIR MEDISCH CENTRUM GRONINGEN1 projects · NL
- ANA1 projects · AT
- ARTTIC1 projects · FR
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1 projects · FR
- BIOBYTE SOLUTIONS GMBH1 projects · DE
- BLEKINGE LAN COUNTY COUNCIL OF BLEKINGE1 projects · SE
- CARGILL HAUBOURDIN SAS1 projects · FR
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Improving Outcome of Necrotizing Fasciitis: Elucidation of Complex Host and Pathogen Signatures that Dictate Severity of Tissue Infection INFECT · 305340 | FP7 | €11,913,591 | €15,680,323 | Details |
Systems medicine of chronic inflammatory bowel disease SYSMEDIBD · 305564 | FP7 | €11,999,998 | €15,784,307 | Details |
A systems biology approach to RESOLVE the molecular pathology of two hallmarks of patients with metabolic syndrome and its co-morbidities; hypertriglyceridemia and low HDL-cholesterol RESOLVE · 305707 | FP7 | €10,548,374 | €13,675,103 | Details |
Metagenomics in Cardiometabolic Diseases METACARDIS · 305312 | FP7 | €11,999,992 | €23,132,096 | Details |